Multicenter Open and Prospective Trial Assessing the Efficacy of Vitamin D Supplementation on Top of Pegylated Interferon Plus Ribavirin in Patients With Chronic Viral Hepatitis C Genotype 1 or 4 Non Responders to Initial Antiviral Therapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Colecalciferol; Peginterferon alfa-2a; Peginterferon alfa-2b; Ribavirin; Vitamin D analogues
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms ANRS VITAVIC
Most Recent Events
- 11 Aug 2014 Biomarkers information updated
- 20 Feb 2012 Actual patient number added 32 according to ClinicalTrials.gov.
- 20 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.